Publikationen, an denen er mitarbeitet Joaquín Sastre Merlín (49)

2022

  1. Consensus on the Definition of Control and Remission in Chronic Urticaria

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269

2020

  1. Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey

    Dermatology Research and Practice, Vol. 2020

2019

  1. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)

    Health and Quality of Life Outcomes, Vol. 17, Núm. 1

  2. Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348

2018

  1. Changing perspectives in atopic dermatitis

    Allergologia et Immunopathologia, Vol. 46, Núm. 4, pp. 397-412

  2. Prospective assessment of diagnostic tests for pediatric penicillin allergy: From clinical history to challenge tests

    Annals of Allergy, Asthma and Immunology, Vol. 121, Núm. 2, pp. 235-244.e3

2017

  1. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe

    Rhinology, Vol. 55, Núm. 1, pp. 34-38

  2. Allergy rhinitis: Similarities and differences between children and adults

    Rhinology, Vol. 55, Núm. 4, pp. 326-331

  3. Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements

    Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 134-144

2016

  1. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study

    Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870

2015

  1. Management of urticaria: Not too complicated, not too simple

    Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743

2013

  1. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain

    Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684

  2. Antihistamines in drivers, aircrew and occupations of risk.

    Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 27-34

  3. Bilastine for the treatment of urticaria

    Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 11, pp. 1537-1544

  4. ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications

    Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 1, pp. 14-19

  5. Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: Analysis of 110 patients in real-life practice

    Expert Opinion on Biological Therapy, Vol. 13, Núm. 9, pp. 1225-1228

  6. H1 antihistamines and benzodiazepines. Pharmacological interactions and their impact on cerebral function.

    Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 17-26

  7. Use of second generation H1 antihistamines in special situations.

    Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 1-16

2012

  1. The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification

    Rhinology, Vol. 50, Núm. 1, pp. 33-36

  2. Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: The PEDRIAL study

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 67, Núm. 11, pp. 1437-1442